Abstract
Patients seropositive for HIV on antiretroviral therapy high (HAART) may exhibit changes in body composition and metabolic termed lipodystrophy syndrome. These changes represent an atherogenic profile, increasing the risk for developing cardiovascular disease. Therefore, it is of great importance to identify early risk for developing these diseases through practical, accessible, accurate …